Y. Cirak Et Al. , "Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A," BJU INTERNATIONAL , vol.110, 2012
Cirak, Y. Et Al. 2012. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. BJU INTERNATIONAL , vol.110 .
Cirak, Y., Varol, U., Atmaca, H., Kisim, A., Sezgin, C., KARABULUT, B., ... Uzunoglu, S.(2012). Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. BJU INTERNATIONAL , vol.110.
Cirak, YALÇIN Et Al. "Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A," BJU INTERNATIONAL , vol.110, 2012
Cirak, YALÇIN Et Al. "Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A." BJU INTERNATIONAL , vol.110, 2012
Cirak, Y. Et Al. (2012) . "Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A." BJU INTERNATIONAL , vol.110.
@article{article, author={YALÇIN ÇIRAK Et Al. }, title={Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A}, journal={BJU INTERNATIONAL}, year=2012}